{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:15:13Z","timestamp":1790111713588,"version":"4.0.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Clinics of North America"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/j.pcl.2013.11.008","type":"journal-article","created":{"date-parts":[[2014,1,28]],"date-time":"2014-01-28T15:48:15Z","timestamp":1390924095000},"page":"347-366","source":"Crossref","is-referenced-by-count":30,"title":["Pediatric Vitiligo"],"prefix":"10.1016","volume":"61","author":[{"given":"Nanette B.","family":"Silverberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pcl.2013.11.008_bib1","first-page":"145","article-title":"Epidemiological study of vitiligo in Surat area, South Gujarat","volume":"61","author":"Mehta","year":"1973","journal-title":"Indian J Med Res"},{"key":"10.1016\/j.pcl.2013.11.008_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1001\/archderm.1977.01640010049006","article-title":"Prevalence of vitiligo. Epidemiological survey on the Isle of Bornholm, Denmark","volume":"113","author":"Howitz","year":"1977","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1046\/j.1365-4362.2000.00880.x","article-title":"Epidemiology of vitiligo in the French West Indies (Isle of Martinique)","volume":"39","author":"Boisseau-Garsaud","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib4","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A\u00a0review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib5","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/pcmr.12065","article-title":"Development and validation of the K-VSCOR for scoring Koebner's phenomenon in vitiligo\/non-segmental vitiligo","volume":"26","author":"Diallo","year":"2013","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pcl.2013.11.008_bib6","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOP.0b013e32833b6ac3","article-title":"Update on childhood vitiligo","volume":"22","author":"Silverberg","year":"2010","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.pcl.2013.11.008_bib7","first-page":"370","article-title":"Childhood vitiligo","volume":"77","author":"Silverberg","year":"2006","journal-title":"Cutis"},{"key":"10.1016\/j.pcl.2013.11.008_bib8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/S0190-9622(98)70194-X","article-title":"Vitiligo","volume":"38","author":"Kovacs","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib9","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1111\/j.1365-2133.2004.06136.x","article-title":"Keratinocytes in the depigmented epidermis of vitiligo are more vulnerable to trauma (suction) than keratinocytes in the normally pigmented epidermis, resulting in their apoptosis","volume":"151","author":"Lee","year":"2004","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jaut.2003.09.006","article-title":"Apoptosis in feathers of Smyth line chickens with autoimmune vitiligo","volume":"22","author":"Wang","year":"2004","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.pcl.2013.11.008_bib11","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/S0190-9622(87)70119-4","article-title":"Childhood vitiligo","volume":"16","author":"Halder","year":"1987","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2340\/00015555-1397","article-title":"Prevalence and clinical profile of vitiligo in China: a community-based study in six cities","volume":"93","author":"Wang","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pcl.2013.11.008_bib13","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/jid.1959.49","article-title":"Vitiligo","volume":"32","author":"Lerner","year":"1959","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib14","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1365-4632.2012.05475.x","article-title":"Epidemiologic study of dermatologic disorders among children in South Sinai, Egypt","volume":"51","author":"Yamamah","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib15","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jamadermatol.2013.4228","article-title":"Association between vitiligo and atopic disorders: a pilot study","volume":"149","author":"Silverberg","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib16","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/j.1365-2133.2012.11002.x","article-title":"Pre- vs. post-pubertal onset of vitiligo: multivariate analysis indicates atopic diathesis association in pre-pubertal onset vitiligo","volume":"167","author":"Ezzedine","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1365-2230.2005.01987.x","article-title":"Vitiligo with inflammatory raised borders, associated with atopic dermatitis","volume":"31","author":"Sugita","year":"2006","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib18","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1111\/j.1365-4632.2006.02907.x","article-title":"Genetic epidemiology of vitiligo: a study of 815 probands and their families from south China","volume":"45","author":"Sun","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib19","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/hmg\/11.6.661","article-title":"Mapping of an autoimmunity susceptibility locus (AIS1) to chromosome 1p31.3-p32.2","volume":"11","author":"Alkhateeb","year":"2002","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.pcl.2013.11.008_bib20","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ng.2272","article-title":"Genome-wide association analyses identify 13\u00a0new susceptibility loci for generalized vitiligo","volume":"44","author":"Jin","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.pcl.2013.11.008_bib21","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ng.603","article-title":"Genome-wide association study for vitiligo identifies susceptibility loci at 6q27 and the MHC","volume":"42","author":"Quan","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/j.pcl.2013.11.008_bib22","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/jid.2012.37","article-title":"Next-generation DNA re-sequencing identifies common variants of TYR and HLA-A that modulate the risk of generalized vitiligo via antigen presentation","volume":"132","author":"Jin","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib23","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3349\/ymj.1996.37.6.365","article-title":"Detection of antibodies to melanocytes in vitiligo by Western immunoblotting","volume":"37","author":"Hann","year":"1996","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.pcl.2013.11.008_bib24","doi-asserted-by":"crossref","first-page":"e35005","DOI":"10.1371\/journal.pone.0035005","article-title":"The immune response to melanoma is limited by thymic selection of self-antigens","volume":"7","author":"Tr\u00e4ger","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.pcl.2013.11.008_bib25","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1111\/cei.12096","article-title":"Immunophenotypic characterization of lymphoid cell infiltrates in vitiligo","volume":"173","author":"Sanchez-Sosa","year":"2013","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.pcl.2013.11.008_bib26","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/00000372-199708000-00014","article-title":"Analysis of the lymphocytic infiltrate in a case of vitiligo","volume":"19","author":"Horn","year":"1997","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.pcl.2013.11.008_bib27","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/j.1755-148X.2011.00920.x","article-title":"Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo","volume":"25","author":"Ben Ahmed","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pcl.2013.11.008_bib28","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.mehy.2010.10.034","article-title":"Possible roles of B lymphocyte activating factor of the tumour necrosis factor family in vitiligo autoimmunity","volume":"76","author":"Lin","year":"2011","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.pcl.2013.11.008_bib29","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1073\/pnas.1222808110","article-title":"NLRP1 haplotypes associated with vitiligo and autoimmunity increase interleukin-1\u03b2 processing via the NLRP1 inflammasome","volume":"110","author":"Levandowski","year":"2013","journal-title":"Proc Natl Acad Sci U\u00a0S\u00a0A"},{"key":"10.1016\/j.pcl.2013.11.008_bib30","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2165\/11318020-000000000-00000","article-title":"Childhood vitiligo in China: clinical profiles and\u00a0immunological findings in 620 cases","volume":"12","author":"Lin","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib31","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4103\/0019-5154.55628","article-title":"Oxidative stress in experimental vitiligo C57BL\/6 mice","volume":"54","author":"Jalel","year":"2009","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib32","doi-asserted-by":"crossref","first-page":"2646","DOI":"10.1038\/jid.2009.143","article-title":"Genetic polymorphisms of glutathione S-transferase and risk of vitiligo in the Chinese population","volume":"129","author":"Liu","year":"2009","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib33","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1755-148X.2011.00942.x","article-title":"NLRP1, a regulator of innate immunity associated with vitiligo","volume":"25","author":"D'Osualdo","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pcl.2013.11.008_bib34","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jaut.2007.07.012","article-title":"Apoptosis of melanocytes in vitiligo results from antibody penetration","volume":"29","author":"Ruiz-Arg\u00fcelles","year":"2007","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.pcl.2013.11.008_bib35","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0378-6323.90942","article-title":"Melanocytorrhagy and apoptosis in vitiligo: connecting jigsaw pieces","volume":"78","author":"Kumar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.pcl.2013.11.008_bib36","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/mmr.2012.1117","article-title":"CD8+ T cells from vitiligo perilesional margins induce autologous melanocyte apoptosis","volume":"7","author":"Wu","year":"2013","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.pcl.2013.11.008_bib37","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1089\/gtmb.2012.0173","article-title":"Fas, Fas Ligand, and vitamin D Receptor FokI gene polymorphisms in patients with type 1 diabetes mellitus in the Aegean region of Turkey","volume":"16","author":"Sahin","year":"2012","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/j.pcl.2013.11.008_bib38","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1177\/1352458511415562","article-title":"Potential association of vitamin D receptor polymorphism Taq1 with multiple sclerosis","volume":"18","author":"Cox","year":"2012","journal-title":"Mult Scler"},{"key":"10.1016\/j.pcl.2013.11.008_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/0961203311422709","article-title":"Vitamin D receptor gene BsmI polymorphism B allele, but not BB genotype, is associated with systemic lupus erythematosus in a Han Chinese population","volume":"21","author":"Luo","year":"2012","journal-title":"Lupus"},{"key":"10.1016\/j.pcl.2013.11.008_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2133.2012.11132.x","article-title":"The association of vitamin D receptor gene polymorphisms and serum 25-hydroxyvitamin D levels with generalized vitiligo","volume":"167","author":"Li","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib41","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.jaad.2009.11.024","article-title":"A\u00a0pilot study assessing the role of 25 hydroxyvitamin D levels in patients with vitiligo vulgaris","volume":"62","author":"Silverberg","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4103\/0019-5154.70680","article-title":"Chemical leukoderma: what's new on etiopathological and clinical aspects?","volume":"55","author":"Ghosh","year":"2010","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib43","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1038\/jid.2012.181","article-title":"Vitiligo-inducing phenols activate the unfolded protein response in melanocytes resulting in upregulation of IL6 and IL8","volume":"132","author":"Toosi","year":"2012","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4103\/0019-5154.92668","article-title":"Serum concentration of IL-6, IL-2, TNF-\u03b1, and IFN\u03b3 in Vitiligo patients","volume":"57","author":"Singh","year":"2012","journal-title":"Indian J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib45","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/bjd.12166","article-title":"Autoimmune thyroid disease in vitiligo: multivariate analysis indicates intricate pathomechanisms","volume":"168","author":"Gey","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib46","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.jaad.2010.08.031","article-title":"Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients","volume":"65","author":"Ezzedine","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.pcl.2013.11.008_bib47","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2009.06.081","article-title":"Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study","volume":"62","author":"Mazereeuw-Hautier","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib48","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S0190-9622(00)90170-1","article-title":"Clinical and histopathologic characteristics of trichrome vitiligo","volume":"42","author":"Hann","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib49","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0738-081X(03)00048-8","article-title":"Vitiligo and leukoderma in children","volume":"21","author":"Herane","year":"2003","journal-title":"Clin Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2013.11.008_bib50","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.sder.2008.02.002","article-title":"Selected applications of technology in the pediatric dermatology office","volume":"27","author":"Ducharme","year":"2008","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.pcl.2013.11.008_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1111\/j.1365-4632.2011.04914.x","article-title":"The incidence of leukotrichia in segmental vitiligo: implication of poor response to medical treatment","volume":"50","author":"Lee","year":"2011","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib52","first-page":"463","article-title":"Thyroid abnormalities in pediatric patients with vitiligo in New York City","volume":"81","author":"Pagovich","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.pcl.2013.11.008_bib53","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000081479","article-title":"Relevance of thyroiditis and of other autoimmune diseases in children with vitiligo","volume":"210","author":"Iacovelli","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.pcl.2013.11.008_bib54","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1687-9856-2011-18","article-title":"Incidence of vitiligo in children with Graves' disease and Hashimoto's thyroiditis","volume":"2011","author":"Prindaville","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.pcl.2013.11.008_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1177\/120347541201600408","article-title":"Vitiligo and associated autoimmune disease: retrospective review of 300 patients","volume":"16","author":"Sawicki","year":"2012","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.pcl.2013.11.008_bib56","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4103\/0378-6323.90944","article-title":"Childhood vitiligo","volume":"78","author":"Palit","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"2","key":"10.1016\/j.pcl.2013.11.008_bib57","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.autrev.2013.07.006","article-title":"Autoimmune polyendocrine syndromes","volume":"13","author":"Cutolo","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pcl.2013.11.008_bib58","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.autrev.2013.01.004","article-title":"Vogt-Koyanagi-Harada syndrome","volume":"12","author":"Greco","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.pcl.2013.11.008_bib59","first-page":"248","article-title":"Vitiligo and thyroid dysfunction in children and adolescents","volume":"19","author":"Pr\u0107i\u0107","year":"2011","journal-title":"Acta Dermatovenerol Croat"},{"key":"10.1016\/j.pcl.2013.11.008_bib60","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jaad.2005.03.032","article-title":"Increased prevalence of chronic autoimmune (Hashimoto's) thyroiditis in children and adolescents with vitiligo","volume":"53","author":"Kakourou","year":"2005","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2013.11.008_bib61","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.jaad.2013.04.050","article-title":"Clinical features of vitiligo associated with comorbid autoimmune disease: a prospective survey","volume":"69","author":"Silverberg","year":"2013","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib62","first-page":"329","article-title":"Segmental vitiligo may not be associated with risk of autoimmune thyroiditis","volume":"9","author":"Silverberg","year":"2011","journal-title":"Skinmed"},{"key":"10.1016\/j.pcl.2013.11.008_bib63","series-title":"Atlas of cutaneous biodiversity","first-page":"38","author":"Silverberg","year":"2012"},{"key":"10.1016\/j.pcl.2013.11.008_bib64","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Vitiligo global issue consensus conference panelists. Revised classification\/nomenclature of vitiligo and related issues: the vitiligo global issues consensus conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.pcl.2013.11.008_bib65","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2230.2010.03965.x","article-title":"Depression, anxiety and health-related quality of life in children and adolescents with vitiligo","volume":"36","author":"Bilgi\u00e7","year":"2011","journal-title":"Clin Exp Dermatol"},{"issue":"5","key":"10.1016\/j.pcl.2013.11.008_bib66","first-page":"248","article-title":"Vitiligo patients seeking depigmentation therapy: a case report and guidelines for psychological screening","volume":"91","author":"Grau","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.pcl.2013.11.008_bib67","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib68","doi-asserted-by":"crossref","unstructured":"Silverberg JI, Silverberg NB. Quality of life impairment in children and adolescents with vitiligo. Pediatr Dermatolog 2013. [Epub ahead of print].","DOI":"10.1111\/pde.12226"},{"key":"10.1016\/j.pcl.2013.11.008_bib69","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1001\/jamadermatol.2013.927","article-title":"Association between vitiligo extent and distribution and quality-of-life impairment","volume":"149","author":"Silverberg","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib70","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/j.1468-3083.2009.03452.x","article-title":"Quality of life and psychological adaptation of Korean adolescents with vitiligo","volume":"24","author":"Choi","year":"2010","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pcl.2013.11.008_bib71","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"key":"10.1016\/j.pcl.2013.11.008_bib72","first-page":"163","article-title":"The psychological aspects of vitiligo","volume":"73","author":"Silvan","year":"2004","journal-title":"Cutis"},{"key":"10.1016\/j.pcl.2013.11.008_bib73","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1067\/mpd.2001.110276","article-title":"Typical halo nevi in childhood: is a biopsy necessary?","volume":"138","author":"Lai","year":"2001","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.pcl.2013.11.008_bib74","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1001\/archdermatol.2011.351","article-title":"Halo nevi association in nonsegmental vitiligo affects age at onset and depigmentation pattern","volume":"148","author":"Ezzedine","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib75","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2133.2011.10709.x","article-title":"Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo","volume":"166","author":"Ezzedine","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib76","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1111\/bjd.12111","article-title":"Decreased risk of melanoma and nonmelanoma skin cancer in patients with vitiligo: a survey among 1307 patients and their partners","volume":"168","author":"Teulings","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib77","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2340\/00015555-0794","article-title":"A\u00a0practical classification of childhood hypopigmentation disorders","volume":"90","author":"Tey","year":"2010","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pcl.2013.11.008_bib78","first-page":"177","article-title":"Management of vitiligo patients and attitude of dermatologists towards vitiligo","volume":"14","author":"Ongenae","year":"2004","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib79","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1046\/j.1365-4362.1999.00822.x","article-title":"Management of vitiligo. Results of a questionnaire among dermatologists in The Netherlands","volume":"38","author":"Njoo","year":"1999","journal-title":"Int J Dermatol"},{"issue":"3","key":"10.1016\/j.pcl.2013.11.008_bib80","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3109\/09546634.2012.762638","article-title":"Vitiligo management strategy in Jeddah, Saudi Arabia as reported by dermatologists and experienced by patients","volume":"25","author":"Ismail","year":"2014","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"1","key":"10.1016\/j.pcl.2013.11.008_bib81","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003263.pub4","article-title":"Interventions for vitiligo","author":"Whitton","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.pcl.2013.11.008_bib82","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1755-148X.2011.00939.x","article-title":"Vitiligo as an inflammatory skin disorder: a therapeutic perspective","volume":"25","author":"Taieb","year":"2011","journal-title":"Pigment Cell Melanoma Res"},{"issue":"1","key":"10.1016\/j.pcl.2013.11.008_bib83","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2133.2012.11197.x","article-title":"Guidelines for the management of vitiligo: the European Dermatology Forum consensus","volume":"168","author":"Taieb","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib84","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/archderm.139.5.571","article-title":"Successful treatment of vitiligo with 0.1% tacrolimus ointment","volume":"139","author":"Travis","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib85","first-page":"507","article-title":"Topical tacrolimus is more effective for treatment of vitiligo in patients of skin of color","volume":"10","author":"Silverberg","year":"2011","journal-title":"J\u00a0Drugs Dermatol"},{"issue":"1","key":"10.1016\/j.pcl.2013.11.008_bib86","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/0378-6323.90949","article-title":"Segmental vitiligo: a randomized controlled trial to evaluate efficacy and safety of 0.1% tacrolimus ointment vs 0.05% fluticasone propionate cream","volume":"78","author":"Kathuria","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.pcl.2013.11.008_bib87","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1067\/mjd.2002.126250","article-title":"Topical tacrolimus for repigmentation of vitiligo","volume":"47","author":"Grimes","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib88","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A\u00a0double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib89","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1111\/j.1365-2133.2011.10351.x","article-title":"A\u00a0double-blind, randomized, placebo-controlled trial of topical tacrolimus 0\u00b71%vs. clobetasol propionate 0\u00b705% in childhood vitiligo","volume":"165","author":"Ho","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib90","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1346-8138.2010.01067.x","article-title":"Effectiveness of 0.1%\u00a0topical tacrolimus in adult and children patients with vitiligo","volume":"38","author":"Udompataikul","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib91","first-page":"5","article-title":"Use of tacrolimus ointment in vitiligo alone or in combination therapy","volume":"14","author":"Berti","year":"2009","journal-title":"Skin Therapy Lett"},{"key":"10.1016\/j.pcl.2013.11.008_bib92","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1001\/archderm.144.4.560","article-title":"Rapid enlargement of a malignant melanoma in a child with vitiligo vulgaris after application of topical tacrolimus","volume":"144","author":"Mikhail","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib93","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archderm.143.9.1223","article-title":"Focal acne during topical tacrolimus therapy for vitiligo","volume":"143","author":"Bakos","year":"2007","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib94","first-page":"490","article-title":"FK506 (tacrolimus) and endothelin combined treatment induces mobility of melanoblasts: new insights into follicular vitiligo repigmentation induced by topical tacrolimus on sun-exposed skin","volume":"164","author":"Lan","year":"2011","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib95","doi-asserted-by":"crossref","first-page":"133","DOI":"10.3109\/09546630903266761","article-title":"Mometasone cream versus pimecrolimus cream for\u00a0the treatment of childhood localized vitiligo","volume":"21","author":"K\u00f6se","year":"2010","journal-title":"J\u00a0Dermatolog Treat"},{"key":"10.1016\/j.pcl.2013.11.008_bib96","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1525-1470.2009.00926.x","article-title":"The efficacy of pimecrolimus 1%\u00a0cream combined with microdermabrasion in the treatment of nonsegmental childhood vitiligo: a randomized placebo-controlled study","volume":"26","author":"Farajzadeh","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib97","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1525-1470.2009.00914.x","article-title":"Combination of 308-nm excimer laser with topical pimecrolimus for the treatment of childhood vitiligo","volume":"26","author":"Hui-Lan","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib98","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib99","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1067\/mjd.2002.120576","article-title":"Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well","volume":"46","author":"Cockayne","year":"2002","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib100","first-page":"e63","article-title":"The therapeutic effects of a topical tretinoin and corticosteroid combination for vitiligo: a placebo-controlled, paired-comparison, left-right study","volume":"12","author":"Kwon","year":"2013","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib101","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1365-4362.1993.tb02754.x","article-title":"Oral mini-pulse therapy with betamethasone in vitiligo patients having extensive or fast-spreading disease","volume":"32","author":"Pasricha","year":"1993","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib102","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1159\/000246705","article-title":"Oral minipulse therapy in vitiligo","volume":"190","author":"Kanwar","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.pcl.2013.11.008_bib103","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2310\/7750.2013.12053","article-title":"Low-dose oral mini-pulse dexamethasone therapy in progressive unstable vitiligo","volume":"17","author":"Kanwar","year":"2013","journal-title":"J\u00a0Cutan Med Surg"},{"key":"10.1016\/j.pcl.2013.11.008_bib104","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1365-4362.1995.tb01570.x","article-title":"Comparison of 0.05% clobetasol propionate cream and topical Puvasol in childhood vitiligo","volume":"34","author":"Khalid","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib105","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1365-4362.1995.tb01571.x","article-title":"Oral photochemotherapy in vitiligo: follow-up, patient compliance","volume":"34","author":"Al Aboosi","year":"1995","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib106","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0190-9622(95)91329-7","article-title":"Treatment of stable vitiligo with autologous epidermal grafting and PUVA","volume":"32","author":"Hann","year":"1995","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib107","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1600-0781.2012.00648.x","article-title":"Evaluation of the effect of disease duration in generalized vitiligo on its clinical response to narrowband ultraviolet B phototherapy","volume":"28","author":"Hallaji","year":"2012","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.pcl.2013.11.008_bib109","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jaad.2006.09.004","article-title":"Efficacy, predictors of response, and long-term follow-up in patients with vitiligo treated with narrowband UVB phototherapy","volume":"56","author":"Nicolaidou","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib110","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1111\/j.1525-1470.2011.01683.x","article-title":"Narrowband ultraviolet B phototherapy in childhood vitiligo: evaluation of results in 28 patients","volume":"29","author":"Percivalle","year":"2012","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1600-0781.2010.00540.x","article-title":"Does topical tacrolimus ointment enhance the efficacy of narrowband ultraviolet B therapy in vitiligo? A left-right comparison study","volume":"26","author":"Majid","year":"2010","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.pcl.2013.11.008_bib112","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1111\/j.1365-2133.2011.10564.x","article-title":"Effect of a preceding laser dermabrasion on the outcome of combined therapy with narrowband ultraviolet B and potent topical steroids for treating nonsegmental vitiligo in resistant localizations","volume":"166","author":"Bayoumi","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib113","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2230.2010.03838.x","article-title":"Narrowband ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of generalized vitiligo","volume":"35","author":"Gamil","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib114","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pcl.2013.11.008_bib115","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/2013.jamadermatol.386","article-title":"The efficacy of afamelanotide and narrowband UV-B phototherapy for repigmentation of vitiligo","volume":"149","author":"Grimes","year":"2013","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib116","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/phpp.12061","article-title":"BB-UVA vs. NB-UVB in the treatment of vitiligo: a randomized controlled clinical study (single blinded)","volume":"29","author":"El-Mofty","year":"2013","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.pcl.2013.11.008_bib117","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1111\/j.1346-8138.2010.01184.x","article-title":"Efficacy of 1-mm minigrafts in treating vitiligo depends on patient age, disease site and vitiligo subtype","volume":"38","author":"Kato","year":"2011","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib118","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s00238-013-0875-7","article-title":"Treatment of vitiligo with autologous cultured keratinocytes in 27 cases","volume":"36","author":"Matsuzaki","year":"2013","journal-title":"Eur J Plast Surg"},{"key":"10.1016\/j.pcl.2013.11.008_bib119","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1346-8138.2011.01391.x","article-title":"Circumcised foreskin may be useful as a donor tissue during an autologous, non-cultured, epidermal cell transplantation for the treatment of widespread vitiligo","volume":"39","author":"Kim","year":"2012","journal-title":"J\u00a0Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib120","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1468-3083.2011.04097.x","article-title":"Successful treatment of vitiligo on the axilla in a 5-year-old child by cultured-melanocyte transplantation","volume":"26","author":"Yao","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pcl.2013.11.008_bib121","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/j.1468-3083.2011.04147.x","article-title":"A\u00a0randomized comparison of excimer laser versus narrow-band ultraviolet B phototherapy after punch grafting in stable vitiligo patients","volume":"26","author":"Linthorst Homan","year":"2012","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.pcl.2013.11.008_bib122","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1177\/0009922810363169","article-title":"Vitiligo therapy in children: a case for considering excimer laser treatment","volume":"49","author":"Patel","year":"2010","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.pcl.2013.11.008_bib123","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/j.1365-2230.2011.04065.x","article-title":"Noncultured epidermal suspension transplantation for the treatment of stable vitiligo in children and adolescents","volume":"36","author":"Sahni","year":"2011","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib124","first-page":"110","article-title":"Corrective camouflage in pediatric dermatology","volume":"79","author":"Tedeschi","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.pcl.2013.11.008_bib125","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1111\/exd.12202","article-title":"Targeting iHSP 70 in vitiligo: a critical step for cure?","volume":"22","author":"Ta\u00efeb","year":"2013","journal-title":"Exp Dermatol"},{"key":"10.1016\/j.pcl.2013.11.008_bib126","first-page":"327","article-title":"Medical phototherapy in childhood skin diseases","volume":"63","author":"Veith","year":"2011","journal-title":"Minerva Pediatr"},{"key":"10.1016\/j.pcl.2013.11.008_bib127","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/j.freeradbiomed.2013.08.189","article-title":"Involvement of superoxide dismutase isoenzymes and their genetic variants in progression of and higher susceptibility to vitiligo","volume":"65C","author":"Laddha","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/j.pcl.2013.11.008_bib128","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1472-6882-12-109","article-title":"Immunity to melanin and to tyrosinase in melanoma patients, and in people with vitiligo","volume":"12","author":"Dor\u0111i\u0107","year":"2012","journal-title":"BMC Complement Altern Med"}],"container-title":["Pediatric Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395513002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031395513002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T18:40:45Z","timestamp":1716489645000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031395513002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4]]},"references-count":128,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S0031395513002113"],"URL":"https:\/\/doi.org\/10.1016\/j.pcl.2013.11.008","relation":{},"ISSN":["0031-3955"],"issn-type":[{"value":"0031-3955","type":"print"}],"subject":[],"published":{"date-parts":[[2014,4]]}}}